Zimmer Biomet Holdings Inc 's Annual Capital Expenditures for the fiscal year ended 2022, increased by 4.16% to $187.90 millions, from $180.40 millions achieved a year ago. Zimmer Biomet Holdings Inc 's 2022 Annual Capital Expenditures performance marks a slow down, from 53.01 % achieved in the fiscal year 2021.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com